Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
orphan products
Pharma
Novartis CEO calls for new drug payment model
New models are needed to assess the value of gene and cell therapies and provide reimbursement, Novartis CEO Vas Narasimhan says.
Angus Liu
May 20, 2019 11:56am
Did Novartis game Europe's orphan program to overprice Lutathera?
Jan 14, 2019 10:50am
Novartis explores 'reinsurance model' for next-gen drugs: FT
Dec 17, 2018 11:34am
Analysts peg Vertex and Alexion as stalwarts in tough 2018
Jan 2, 2018 9:28am
The world's 10 most pricey meds, topped at $1.2M
Apr 19, 2017 11:02am
Eight senators pile on to Marathon's $89K Emflaza price tag
Mar 6, 2017 10:30am
